AQR Capital Management - SCICLONE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$11,545,000
+19.0%
1,030,748
+16.9%
0.01%
+7.7%
Q2 2017$9,701,000
+15.2%
881,896
+2.7%
0.01%
+18.2%
Q1 2017$8,419,000
-6.8%
859,048
+2.7%
0.01%
-8.3%
Q4 2016$9,037,000
+0.3%
836,809
-4.8%
0.01%
-14.3%
Q3 2016$9,008,000
+23.0%
878,867
+56.7%
0.01%
+7.7%
Q2 2016$7,326,000
-5.1%
560,973
-20.1%
0.01%
-7.1%
Q1 2016$7,721,000
-4.3%
701,876
-20.0%
0.01%0.0%
Q4 2015$8,069,000
+50.8%
877,076
+13.7%
0.01%
+27.3%
Q3 2015$5,351,000
-2.5%
771,086
+38.0%
0.01%0.0%
Q2 2015$5,488,000
+192.1%
558,851
+163.5%
0.01%
+175.0%
Q1 2015$1,879,000
+391.9%
212,109
+386.5%
0.00%
+300.0%
Q4 2014$382,000
+297.9%
43,600
+213.7%
0.00%
Q3 2014$96,000
-37.7%
13,900
-52.5%
0.00%
Q2 2014$154,000
-68.3%
29,280
-72.6%
0.00%
-100.0%
Q1 2014$486,000
-57.7%
106,880
-53.1%
0.00%
-66.7%
Q4 2013$1,149,000
-37.8%
227,980
-37.4%
0.00%
-57.1%
Q3 2013$1,847,000
-52.0%
364,380
-53.0%
0.01%
-50.0%
Q2 2013$3,846,000
+67.6%
775,400
+45.6%
0.01%
+40.0%
Q4 2012$2,295,000532,5000.01%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,249,200$13,491,0008.04%
Nantahala Capital Management 2,169,043$23,426,0002.43%
Sensato Investors LLC 429,069$4,634,0000.80%
TFS CAPITAL LLC 144,575$1,561,0000.42%
Sapphire Star Partners LP 27,938$302,0000.34%
Ativo Capital Management LLC 123,428$1,333,0000.31%
Zebra Capital Management LLC 55,618$601,0000.18%
MENTA CAPITAL LLC 191,474$2,068,0000.17%
GSA CAPITAL PARTNERS LLP 231,214$2,497,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,919,172$20,729,0000.10%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders